Certain Options of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 20-DEC-2023. These Options will be under lockup for 16 days starting from 4-DEC-2023 to 20-DEC-2023.

Details:
Directors and officers have agreed, subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our common stock or securities convertible into or exercisable or exchangeable for our common stock for a period of 15 days after the closing date of this offering.